lymphatic vessel hyperplasia_Kdr<tm1.1Jamb>/Kdr<tm1.1Jamb>,Tg(KRT14-cre)1Efu/0

http://metadb.riken.jp/0004106I129S1Sv129X1SvJICRKdrtm11JambKdrtm11JambTgKRT14cre1Efu0Kdrtm11JambTgKRT14cre1Efu

lymphatic vessel hyperplasia_Kdr<tm1.1Jamb>/Kdr<tm1.1Jamb>,Tg(KRT14-cre)1Efu/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• kinase insert domain protein receptor
  http://metadb.riken.jp/db/mgi_rdf/MGI:96683
• transgene insertion 1, Elaine Fuchs
  http://metadb.riken.jp/db/mgi_rdf/MGI:1926453

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kdr<tm1.1Jamb>/Kdr<tm1.1Jamb>,Tg(KRT14-cre)1Efu/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kdr<tm1.1Jamb>|Tg(KRT14-cre)1Efu

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * ICR

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• lymphatic vessel hyperplasia
  http://purl.obolibrary.org/obo/MP_0004106

文献

http://purl.org/net/cito/citesAsAuthority

• Romulo J C. Albuquerque, et.al., Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth., Nature medicine, 2009, 15
  http://rdf.ncbi.nlm.nih.gov/pubmed/19668192